partner
Drug Companies Keep Merging. Why That’s Bad For Consumers and Innovation.
Over 30 years, dramatic consolidation has meant higher prices, fewer treatment options and less incentive to innovate.
by Robin Feldman via Made By History on April 6, 2021
